相关实验视频
Updated: Jun 17, 2025

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
3.7K
工程化线粒体移植作为一种抗衰老疗法
Rui Zhao1,2, Chen Dong1,2, Qian Liang1,2
1Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, China.
Aging and disease
|August 9, 2024
概括
线粒体移植提供了一种新的方法来对抗衰老和相关疾病,通过用健康的线粒体取代受损的线粒体. 这种疗法对神经退行和心血管衰老等疾病有前途.
科学领域:
- 老年学和再生医学的研究.
- 线粒体生物学和治疗学
背景情况:
- 衰老是一个复杂的生物过程,与线粒体功能障碍密切相关,其特点是线粒体质量和活性下降.
- 线粒体功能障碍对衰老和与年龄有关的疾病的发展有很大影响,使线粒体成为关键的治疗点.
- 目前针对线粒体的抗衰老策略,如老化药物和抗氧化剂,可能会产生长期不良影响.
研究的目的:
- 引入线粒体移植作为一种新的治疗策略,以缓解衰老和相关疾病.
- 审查线粒体移植在治疗与年龄有关的疾病中的当前状态和转化潜力.
主要方法:
- 本综述综合了关于线粒体移植的现有研究,重点关注其在衰老中的应用.
- 这篇评论讨论了健康的线粒体从供体细胞转移到受体细胞以恢复线粒体功能.
主要成果:
- 线粒体移植已经在打击衰老疾病方面取得了成功的应用,包括神经退行性疾病,心血管衰老和生殖衰老.
- 该疗法突出了临床抗衰老干预措施的显著翻译潜力.
结论:
- 线粒体移植对线粒体功能障碍和衰老的现有疗法提供了一个有希望的替代方案.
- 需要进一步的研究来应对这些挑战,并利用线粒体移植在抗衰老治疗中的机会.
更多相关视频
06:50Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
794
11:13MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells
Published on: February 22, 2017
12.8K
相关概念视频
Mitochondria
11.7K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
11.7K
Electron Transport Chain: Complex I and II
12.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.5K